Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 7/2013

01-09-2013 | Original Paper

Sexual Risk Behaviors among Club Drug Users in Shanghai, China: Prevalence and Correlates

Authors: Yingying Ding, Na He, Weiming Zhu, Roger Detels

Published in: AIDS and Behavior | Issue 7/2013

Login to get access

Abstract

We surveyed 276 club drug users in Shanghai, China. Overall, 43.8 % reported ≥2 sex partners in the past 30 days, and 48.9 % reported having sex with non-regular partners, 67.4 % of whom had unprotected sex. Having ≥2 recent sex partners was associated with being 35 years or older, male, living with friends or others, introduced to club drug use by non-regular sex partners, using methamphetamine recently, self-identified as gay/lesbian or bisexual, had sexual debut before 20 years old, and recently had sex under the influence of drugs. Having unprotected sex with non-regular partners in the past 30 days was associated with lower education levels, having sex to obtain drugs, and lower levels of HIV/AIDS knowledge. Club drug users should be targeted for intervention programs. Future research needs to identify other protective and risk factors for sexual risk behaviors and design interventions to reduce club drug use and associated sexual risk behaviors.
Literature
1.
Degenhardt L, Copeland J, Dillon P. Recent trends in the use of “club drugs”: an Australian review. Subst Use Misuse. 2005;40(9–10):1241–56.PubMedCrossRef
2.
3.
4.
5.
Drumright LN, Patterson TL, Strathdee SA. Club drugs as causal risk factors for HIV acquisition among men who have sex with men: a review. Subst Use Misuse. 2006;41(10–12):1551–601.PubMedCrossRef
6.
Maxwell J. Party drugs: properties, prevalence, patterns, and problems. Subst Use Misuse. 2005;40:1203–40.PubMedCrossRef
7.
Mansergh G, Colfax GN, Marks G, Rader M, Guzman R, Buchbinder S. The circuit party men’s health survey: findings and implications for gay and bisexual men. Am J Pub Hlth. 2001;91(6):953–8.CrossRef
8.
Mattison AM, Ross MW, Wolfson T. San Diego HIV Neurobehavioral Research Center Group. Circuit party attendance, club drug use, and unsafe sex in gay men. J Subst Abuse. 2001;13(1–2):119–26.PubMedCrossRef
9.
10.
Parsons JT, Kelly BC, Weiser JD. Initiation into methamphetamine use for young gay and bisexual men. Drug Alcohol Depend. 2007;90(2–3):135–44.PubMedCrossRef
11.
Jia Z, Wang W, Dye C, Bao Y, Liu Z, Lu L. Exploratory analysis of the association between new-type drug use and sexual transmission of HIV in China. Am J Drug Alcohol Abuse. 2010;36(2):130–3.PubMedCrossRef
12.
Yang X, Xia G. Causes and consequences of increasing club drug use in China: a descriptive assessment. Subst Use Misuse. 2010;45(1–2):224–39.PubMedCrossRef
13.
Halkitis PN, Parsons JT. Recreational drug use and HIV-risk sexual behavior among men frequenting gay social venues. J Gay Lesbian Soc Serv. 2002;14(4):19–39.CrossRef
14.
15.
Halkitis PN, Shrem MT, Martin FW. Sexual behavior patterns of methamphetamine using gay and bisexual men in New York City. Subst Use Misuse. 2005;40:703–19.PubMedCrossRef
16.
Halkitis PN, Mukherjee PP, Palamar JJ. Longitudinal modeling of methamphetamine use and sexual risk behaviors in gay and bisexual men. AIDS Behav. 2009;13(4):783–91.PubMedCrossRef
17.
Klitzman RL, Greenberg JD, Pollack LM, Dolezal C. MDMA (“ecstasy”) use and its association with high risk behaviors, mental health, and other factors among gay/bisexual men in New York City. Drug Alcohol Depend. 2002;66(2):115–25.PubMedCrossRef
18.
Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44:174–99.CrossRef
19.
Heckathorn DD. Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl. 2002;49:11–34.CrossRef
20.
Hathaway AD, Hyshka E, Erickson PG, et al. RDS: an investigation of respondent driven sampling as a method of recruiting mainstream marijuana users. Harm Reduct J. 2010;9(7):15.CrossRef
21.
Heckathorn DD, Semaan S, Broadhead RS, Hughes JJ. Extensions of respondent-driven sampling: a new approach to the study of injection drug users aged 18–25. AIDS Behav. 2002;6:55–67.CrossRef
22.
Platt L, Wall M, Rhodes T, et al. Methods to recruit hard-to-reach groups: comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia. J Urban Hlth. 2006;83(Suppl 6):i39–53.CrossRef
23.
Wang J, Carlson RG, Falck RS, Siegal HA, Rahman A, Li L. Respondent-driven sampling to recruit MDMA users: a methodological assessment. Drug Alc Depend. 2005;78(2):147–57.CrossRef
24.
25.
Li L, Ji G, Liang LJ, Ding Y, Tian J, Xiao Y. A multi-level intervention for HIV affected families: together for empowerment activities (TEA). Soc Sci Med. 2011;73(8):1214–21.PubMedCrossRef
26.
Li L, Liang L, Ding Y, Ji G. Facing HIV as a family: predicting depressive symptoms with correlated responses. J Fam Psychol. 2011;25(2):202–9.PubMedCrossRef
27.
Salganik MJ. Variance estimation, design effects, and sample size calculations for respondent-driven sampling. J Urban Hlth. 2006;83(Suppl 7):98–112.CrossRef
28.
Salganik MJ, Heckathorn DD. Sampling and estimation in hidden populations using respondent-driven sampling. Sociol Methodol. 2004;34:193–239.CrossRef
29.
Heckathorn DD. Extensions of respondent driven sampling: analysing continuous variables and controlling for differential recruitment. Sociol Methodol. 2007;37(1):151–207.CrossRef
30.
Johnston L, O’Bra H, Chopra M, et al. The associations of voluntary counseling and testing acceptance and the perceived likelihood of being HIV-infected among men with multiple sex partners in a South African township. AIDS Behav. 2010;14(4):922–31.PubMedCrossRef
31.
Jerome RC, Halkitis PN, Siconolfi DE. Club drug use, sexual behavior, and HIV seroconversion: a qualitative study of motivations. Subst Use Misuse. 2009;44(3):431–47.PubMedCrossRef
32.
Weeks MR, Liao S, Li F, et al. Challenges, strategies, and lessons learned from a participatory community intervention study to promote female condoms among rural sex workers in Southern China. AIDS Educ Prev. 2010;22(3):252–71.PubMedCrossRef
33.
Wu Z, Rou K, Cui H. The HIV/AIDS epidemic in China: history, current strategies and future challenges. AIDS Educ Prev. 2004;16(3 Suppl A):7–17.PubMedCrossRef
34.
Zhang K, Detels R, Liao S, Cohen M, Yu D. China’s HIV/AIDS epidemic: continuing challenges. Lancet. 2008;372(9652):1791–3.PubMedCrossRef
35.
Do M, Meekers D. Multiple sex partners and perceived risk of HIV infection in Zambia: attitudinal determinants and gender differences. AIDS Care. 2009;21(10):1211–21.PubMedCrossRef
36.
Uchudi J, Magadi M, Mostazir M. A multilevel analysis of the determinants of high-risk sexual behaviour in sub-Saharan Africa. J Biosoc Sci. 2012;44(3):289–311.PubMedCrossRef
37.
Li L, Ding YY, Wu Z, Rotheram-Borus MJ. NIMH Collaborative HIV/STD Prevention Trial Group. Normative beliefs and sexual risk in China. AIDS Behav. 2011;15(6):1251–8.PubMedCrossRef
38.
Sterk CE, Klein H, Elifson KW. Young adult Ecstasy users and multiple sexual partners: understanding the factors underlying this HIV risk practice. J Psychoactive Drugs. 2008;40(3):237–44.PubMedCrossRef
39.
Halkitis PN, Green KA, Mourgues P. Longitudinal investigation of methamphetamine use among gay and bisexual men in New York City: findings from Project BUMPS. J Urban Hlth. 2005;82(1 Suppl 1):i18–25.CrossRef
40.
Semple SJ, Patterson TL, Grant I. The context of sexual risk behavior among heterosexual methamphetamine users. Addict Behav. 2004;29(4):807–10.PubMedCrossRef
41.
Semple SJ, Gra I, Patterson TL. Negative self-perceptions and sexual risk behavior among heterosexual methamphetamine users. Subst Use Misuse. 2005;40(12):1797–810.PubMedCrossRef
42.
Taylor MM, Aynalem G, Smith LV, Montoya J, Kerndt P. Methamphetamine use and sexual risk behaviours among men who have sex with men diagnosed with early syphilis in Los Angeles County. Int J STD AIDS. 2007;18(2):93–7.PubMedCrossRef
43.
Anglin MD, Burke C, Perrochet B, Stamper E, Dawud-Noursi S. History of the methamphetamine problem. J Psychoactive Drugs. 2000;32(2):137–41.PubMedCrossRef
44.
Green AI. “Chem friendly”: the institutional basis of “club drug” use in a sample of urban gay men. Deviant Behav. 2003;24(5):427–47.CrossRef
45.
Kurtz SP. Post-circuit blues: motivations and consequences of cystal meth use among gay men in Miami. AIDS Behav. 2005;2005(9):63–72.CrossRef
46.
Novoa RA, Ompad DC, Wu Y, Vlahov D, Galea S. Ecstasy use and its association with sexual behaviors among drug users in New York City. J Commun Hlth. 2005;30(5):331–43.
47.
Leigh BC. The relationship of substance use during sex to high-risk sexual activity. J Sex Res. 1990;27:199–213.CrossRef
48.
Calsyn DA, Cousins SJ, Hatch-Maillette MA, et al. Sex under the influence of drugs or alcohol: common for men in substance abuse treatment and associated with high-risk sexual behavior. Am J Addict. 2010;19(2):119–27.PubMedCrossRef
49.
Calzavara LM, Coates RA, Raboud JM, et al. Ongoing high-risk sexual behaviors in relation to recreational drug use in sexual encounters. Analysis of 5 years of data from the Toronto sexual contact study. Ann Epidemiol. 1993;3(3):272–80.PubMedCrossRef
50.
McElrath K. MDMA and sexual behavior: ecstasy users’ perceptions about sexuality and sexual risk. Subst Use Misuse. 2005;40(9–10):1461–77.PubMedCrossRef
51.
Rusch M, Lampinen TM, Schilder A, Hogg RS. Unprotected anal intercourse associated with recreational drug use among young men who have sex with men depends on partner type and intercourse role. Sex Transm Dis. 2004;31(8):492–8.PubMedCrossRef
52.
Degenhardt L. Drug use and risk behaviour among regular ecstasy users: does sexuality make a difference? Cult Hlth Sex. 2005;7(6):599–614.CrossRef
53.
Williams CT, Mackesy-Amiti ME, McKirnan DJ, Ouellet LJ. Differences in sexual identity, risk practices, and sex partners between bisexual men and other men among a low-income drug-using sample. J Urban Hlth. 2009;86(Suppl 1):93–106.CrossRef
54.
Williams CT, Latkin CA. The role of depressive symptoms in predicting sex with multiple and high-risk partners. JAIDS. 2005;38(1):69–73.PubMedCrossRef
55.
Ahmed S, Lutalo T, Wawer M, et al. HIV incidence and sexually transmitted disease prevalence associated with condom use: a population study in Rakai. Uganda AIDS. 2001;15(16):2171–9.CrossRef
56.
Kemboi GJ, Kennedy O, Ntabo OM. Socio-cultural factors that perpetuate the spread of HIV among women and girls in Keiyo District, Kenya. Int J Soc Anthropol. 2011;3(5):147–52.
57.
Hutton HE, Lyketsos CG, Zenilman JM, Thompson RE, Erbelding EJ. Depression and HIV risk behaviors among patients in a sexually transmitted disease clinic. Am J Psychiatry. 2004;161(5):912–4.PubMedCrossRef
58.
Lehrer JA, Shrier LA, Gortmaker S, Buka S. Depressive symptoms as a longitudinal predictor of sexual risk behaviors among US middle and high school students. Pediatrics. 2006;118:189–200.PubMedCrossRef
Metadata
Title
Sexual Risk Behaviors among Club Drug Users in Shanghai, China: Prevalence and Correlates
Authors
Yingying Ding
Na He
Weiming Zhu
Roger Detels
Publication date
01-09-2013
Publisher
Springer US
Published in
AIDS and Behavior / Issue 7/2013
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-012-0380-1

Other articles of this Issue 7/2013

AIDS and Behavior 7/2013 Go to the issue

Original Research

From Coitus to Concurrency: Sexual Partnership Characteristics and Risk Behaviors of 15–19 Year Old Men Recruited from Urban Venues in Tanzania

Original Paper

HIV Disease Burden and Related Risk Behaviours Among Men Who Have Sex with Men in Yuxi Prefecture, Yunnan Province, China: 2010−2011

Substantive Review

Respondent Driven Sampling for HIV Biological and Behavioral Surveillance in Latin America and the Caribbean

Brief Report

HIV Test Avoidance Among People Who Inject Drugs in Thailand

Original Paper

Non-consensual Sex and Association with Incident HIV Infection Among Women: A Cohort Study in Rural Uganda, 1990–2008

Original Paper

A Peer-Educator Network HIV Prevention Intervention Among Injection Drug Users: Results of a Randomized Controlled Trial in St. Petersburg, Russia
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits